NurExone Biologic Inc.
NRX.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -48.51% | -81.94% | 29.39% | 120.73% | 171.02% |
| Total Receivables | -76.54% | -65.38% | 29.59% | 215.85% | 165.19% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 45.61% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 28.13% | -96.66% | -24.07% | -24.07% |
| Total Current Assets | -29.85% | -62.90% | -17.56% | 120.72% | 160.43% |
|
|
|||||
| Total Current Assets | -29.85% | -62.90% | -17.56% | 120.72% | 160.43% |
| Net Property, Plant & Equipment | 79.33% | 66.88% | 329.26% | 499.24% | 257.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -13.00% | -48.33% | 12.49% | 156.13% | 171.84% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 90.17% | -19.05% | -38.14% | -36.06% | -39.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -88.89% | -- | -- |
| Total Finance Division Other Current Liabilities | 81.77% | 179.39% | -60.69% | 447.92% | 143.79% |
| Total Other Current Liabilities | 81.77% | 179.39% | -60.69% | 447.92% | 143.79% |
| Total Current Liabilities | 84.43% | 52.76% | -79.14% | -30.18% | 24.94% |
|
|
|||||
| Total Current Liabilities | 84.43% | 52.76% | -79.14% | -30.18% | 24.94% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 264.00% | 29.17% | 1,450.00% | 933.33% | 177.78% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 60.27% | 92.00% | 253.52% | 243.75% | 94.67% |
| Total Liabilities | 85.77% | 61.25% | -65.67% | -0.58% | 37.62% |
|
|
|||||
| Common Stock & APIC | 35.21% | 23.74% | 44.87% | 46.29% | 49.21% |
| Retained Earnings | -38.76% | -38.71% | -35.88% | -31.79% | -34.05% |
| Treasury Stock & Other | -31.59% | -20.44% | 55.57% | 43.18% | 30.22% |
| Total Common Equity | -40.50% | -63.76% | 831.75% | 306.10% | 273.19% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -40.50% | -63.76% | 831.75% | 306.10% | 273.19% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -40.50% | -63.76% | 831.75% | 306.10% | 273.19% |
|
|
|||||